Eiko LifeSciences to acquire 51% in SSM Formulations for ₹18 Cr

Eiko LifeSciences Limited approved acquiring a 51% stake in SSM Formulations for ₹18 crore, making it a subsidiary with over ₹27 crore FY 2024-25 turnover. The Board also cleared raising up to ₹21.86 crore through 33 lakh Warrants and 6.75 lakh Equity Shares at ₹55 each for Promoter and Public categories.